Monsanto acquires Rosetta Green
Monsanto has completed the acquisition of Israeli agricultural biotechnology company Rosetta Green (Jerusalem). The purchase includes almost all Rosetta assets and certain liabilities. The deal was agreed in early February ( Agrow No 658, p 3). Rosetta Green develops improved traits such as stress tolerance and improved disease resistance, applying its proprietary microRNA genes in major crops including cotton, maize and soybeans.